Myocardial infarction is a prevalent major cardiovascular event that arises from myocardial
ischemia with or without reperfusion, and basic and translational research is needed to …

The potential for ischemic preconditioning to reduce infarct size was first recognized more
than 30 years ago [180]. Despite extension of the concept to ischemic postcondition‑ing …

Functional particles are prepared directly by heterogeneous polymerization, eg emulsion
polymerization and dispersion polymerization. Modification of existing particles is another …

Background—Scatter factor/hepatocyte growth factor (SF/HGF) is a pleiotropic growth factor
that stimulates proliferation and migration of endothelial cells (ECs) via the c-Met receptor …

Objective: The purpose of the present study was to investigate whether apoptosis is
triggered during ischemia (I) and reperfusion (R) and whether I/R-induced apoptosis is …

The translation of successful preclinical and clinical proof-of-concept studies on
cardioprotection to the benefit of patients with reperfused acute myocardial infarction has …

Objectives. This study was designed to investigate the effects of decreased aortic
compliance on the coronary circulation. Background. A decrease in aortic compliance due to …

Rationale: Reduction of myocardial infarct size by remote ischemic preconditioning (RIPC),
that is, cycles of ischemia/reperfusion in an organ remote from the heart before sustained …

Objectives: We sought to investigate the effect of a catheter-mounted microaxial blood pump
(Impella, Aachen, Germany) on myocardial infarct size. Background: The small rotary blood …

The no-reflow phenomenon has been studied extensively in the basic science laboratory
and has entered the clinical arena. No-reflow, which develops largely within the first 2h of …